(Q46239910)

20 December 2017

title

The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis (English)

1 reference

20 December 2017

multicenter clinical trial

main subject

osteoporosis

0 references

1 reference

H M Zhu

1

1 reference

20 December 2017

L Qin

2

1 reference

20 December 2017

P Garnero

3

1 reference

20 December 2017

H K Genant

4

1 reference

20 December 2017

G Zhang

5

1 reference

20 December 2017

K Dai

6

1 reference

20 December 2017

X Yao

7

1 reference

20 December 2017

G Gu

8

1 reference

20 December 2017

Y Hao

9

1 reference

20 December 2017

Z Li

10

1 reference

20 December 2017

Y Zhao

11

1 reference

20 December 2017

W Li

12

1 reference

20 December 2017

J Yang

13

1 reference

20 December 2017

X Zhao

14

1 reference

20 December 2017

D Shi

15

1 reference

20 December 2017

T Fuerst

16

1 reference

20 December 2017

Y Lu

17

1 reference

20 December 2017

H Li

18

1 reference

20 December 2017

X Zhang

19

1 reference

20 December 2017

C Li

20

1 reference

20 December 2017

J Zhao

21

1 reference

20 December 2017

Q Wu

22

1 reference

20 December 2017

S J Zhao

23

1 reference

20 December 2017

language of work or name

English

0 references

publication date

20 April 2011

1 reference

20 December 2017

Osteoporosis International

published in

1 reference

20 December 2017

volume

23

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

1317-1327

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-011-1577-2

exact match

0 references

cites work

Predictors of hot flushes in postmenopausal women who receive raloxifene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

The effects of tibolone in older postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Trace analysis of icariin in human serum with dansyl chloride derivatization after oral administration of Epimedium decoction by liquid chromatography tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Increasing options for the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Generalized low bone mass of girls with adolescent idiopathic scoliosis is related to inadequate calcium intake and weight bearing physical activity in peripubertal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Side effects of phytoestrogens: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Pharmacokinetics of prenylflavonoids and correlations with the dynamics of estrogen action in sera following ingestion of a standardized Epimedium extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

LC-MS/MS method for the simultaneous determination of icariin and its major metabolites in rat plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1577-2

Consensus development conference: prophylaxis and treatment of osteoporosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21505910

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21505910

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21505910

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00198-011-1577-2

1 reference

20 December 2017

PubMed ID

21505910

1 reference

20 December 2017